Enveric Biosciences (ENVB) Receivables - Net (2015 - 2020)
Enveric Biosciences' Receivables - Net was $7.56 million in Q3 2020, down 0.6% from $7.61 million a year earlier but up 3.7% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Receivables - Net (2015 - 2020) Analysis & Trends
At the end of FY2019, Receivables - Net at Enveric Biosciences came in at $6.38 million, down 18.9% from FY2018.
- Receivables - Net shows a four-year compound annual growth rate of 7.0% (FY2015 to FY2019).
- In earlier years, Receivables - Net was $7.87 million in FY2018 (-10.9%), $8.84 million in FY2017 (+9.7%), $8.06 million in FY2016 (+65.4%) and $4.87 million in FY2015.
- Quarterly Receivables - Net has moved between $4.13 million (Q2 2016) and $9.59 million (Q1 2017) over five years.
- Compared with a year earlier, Receivables - Net has declined for five straight quarters, with an average decline of 5.5% over the last eight quarters.
- The best year-over-year quarter for Receivables - Net over five years was Q2 2017 (growth of 111.0%); the worst was Q4 2019 (a decline of 18.9%).
- Per Business Quant data, ENVB's Receivables - Net in the three quarters before Q3 2020 was $7.29 million (Q2 2020), $8.1 million (Q1 2020) and $6.38 million (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Enveric Biosciences | 6.02 Mn | -15.62 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 7.56 Mn |
| Jun 30, 2020 | 7.29 Mn |
| Mar 31, 2020 | 8.10 Mn |
| Dec 31, 2019 | 6.38 Mn |
| Sep 30, 2019 | 7.61 Mn |
| Jun 30, 2019 | 8.54 Mn |
| Mar 31, 2019 | 8.90 Mn |
| Dec 31, 2018 | 7.87 Mn |
| Sep 30, 2018 | 7.83 Mn |
| Jun 30, 2018 | 7.94 Mn |
| Mar 31, 2018 | 8.46 Mn |
| Dec 31, 2017 | 8.84 Mn |
| Sep 30, 2017 | 9.17 Mn |
| Jun 30, 2017 | 8.72 Mn |
| Mar 31, 2017 | 9.59 Mn |
| Dec 31, 2016 | 8.06 Mn |
| Sep 30, 2016 | 7.72 Mn |
| Jun 30, 2016 | 4.13 Mn |
| Mar 31, 2016 | 4.93 Mn |
| Dec 31, 2015 | 4.87 Mn |
API Access
Enveric Biosciences Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();